The identification of two cellular receptors that likely contribute to the genesis of hormone-dependent breast cancer points the way to new, highly targeted therapies against the disease, says a team led by scientists at Weill Cornell Medical College in New York City.The finding also helps explain how daily use of medicines such as aspirin might help keep these breast tumors at bay.

[News Source]